PIK3CA c.1922A>C ;(p.Y641S)

Variant ID: 3-178937747-A-C

NM_006218.2(PIK3CA):c.1922A>C;(p.Y641S)

This variant was identified in 6 publications

View GRCh38 version.




Publications:


Gene Transcription as a Therapeutic Target in Leukemia.

International Journal Of Molecular Sciences
Khamidullina, Alvina I AI; Varlamova, Ekaterina A EA; Hammoud, Nour Alhuda NA; Yastrebova, Margarita A MA; Bruter, Alexandra V AV
Publication Date: 2021-07-08

Variant appearance in text: PI3K: Y641S
PubMed Link: 34298959
Variant Present in the following documents:
  • Main text
View BVdb publication page



The Impact of Epigenetic Modifications in Myeloid Malignancies.

International Journal Of Molecular Sciences
Venney, Deirdra D; Mohd-Sarip, Adone A; Mills, Ken I KI
Publication Date: 2021-05-09

Variant appearance in text: PI3K: Y641S
PubMed Link: 34065087
Variant Present in the following documents:
  • Main text
View BVdb publication page



Clinical utility of target capture-based panel sequencing in hematological malignancies: A multicenter feasibility study.

Cancer Science
Yasuda, Takahiko T; Sanada, Masashi M; Nishijima, Dai D; Kanamori, Takashi T; Iijima, Yuka Y; Hattori, Hiroyoshi H; Saito, Akiko A; Miyoshi, Hiroaki H; Ishikawa, Yuichi Y; Asou, Norio N; Usuki, Kensuke K; Hirabayashi, Shinsuke S; Kato, Motohiro M; Ri, Masaki M; Handa, Hiroshi H; Ishida, Tadao T; Shibayama, Hirohiko H; Abe, Masahiro M; Iriyama, Chisako C; Karube, Kennosuke K; Nishikori, Momoko M; Ohshima, Koichi K; Kataoka, Keisuke K; Yoshida, Kenichi K; Shiraishi, Yuichi Y; Goto, Hiroaki H; Adachi, Souichi S; Kobayashi, Ryoji R; Kiyoi, Hitoshi H; Miyazaki, Yasushi Y; Ogawa, Seishi S; Kurahashi, Hiroki H; Yokoyama, Hisayuki H; Manabe, Atsushi A; Iida, Shinsuke S; Tomita, Akihiro A; Horibe, Keizo K
Publication Date: 2020-09

Variant appearance in text: PIK3CA: Y641S
PubMed Link: 32619037
Variant Present in the following documents:
  • CAS-111-3367-s004.xlsx, sheet 3
View BVdb publication page



EZH2 abnormalities in lymphoid malignancies: underlying mechanisms and therapeutic implications.

Journal Of Hematology & Oncology
Li, Boheng B; Chng, Wee-Joo WJ
Publication Date: 2019-11-21

Variant appearance in text: PI3K: Y641S
PubMed Link: 31752930
Variant Present in the following documents:
  • Main text
  • 13045_2019_Article_814.pdf
View BVdb publication page



Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway.

Nature Genetics
Shain, A Hunter AH; Garrido, Maria M; Botton, Thomas T; Talevich, Eric E; Yeh, Iwei I; Sanborn, J Zachary JZ; Chung, Jongsuk J; Wang, Nicholas J NJ; Kakavand, Hojabr H; Mann, Graham J GJ; Thompson, John F JF; Wiesner, Thomas T; Roy, Ritu R; Olshen, Adam B AB; Gagnon, Alexander A; Gray, Joe W JW; Huh, Nam N; Hur, Joe S JS; Busam, Klaus J KJ; Scolyer, Richard A RA; Cho, Raymond J RJ; Murali, Rajmohan R; Bastian, Boris C BC
Publication Date: 2015-10

Variant appearance in text: PIK3CA: Y641S
PubMed Link: 26343386
Variant Present in the following documents:
  • Main text
View BVdb publication page



Predicting the functional impact of protein mutations: application to cancer genomics.

Nucleic Acids Research
Reva, Boris B; Antipin, Yevgeniy Y; Sander, Chris C
Publication Date: 2011-09-01

Variant appearance in text: PIK3CA: Y641S
PubMed Link: 21727090
Variant Present in the following documents:
  • supp_gkr407_Supplement2_Table_SM1_COSMIC_mutations.xls, sheet 1
View BVdb publication page